Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?
Ritu Salani, MD, MBA
Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
Diversity in HER2 Expression Among Gynecologic Cancers
Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors
Shubham Pant, MD, MBBS
Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents
HER2-Targeted ADCs in Advanced NSCLC: A Case-Based Approach to Targeted Treatment for Metastatic Disease
Justin Gainor, MD
Jacob Sands, MD
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Jody Takemoto, PhD, MEd
David Braun
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Munir Ghesani, MD
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
David Braun, MD, PhD
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Hannah Lee, MD
Enhancing HCC Outcomes Through Multidisciplinary Care
Charles Turck, PharmD, BCPS, BCCCP
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Robert Wong, MD
An Overview of the Fundamentals of PET-CT Imaging
Key Highlights from SNMMI 2024
An Exploration of Multiple Myeloma Treatments
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.